Presentation is loading. Please wait.

Presentation is loading. Please wait.

M. A. O. Kinney, M. E. Warner, D. M. Nagorney, J. Rubin, D. R

Similar presentations


Presentation on theme: "M. A. O. Kinney, M. E. Warner, D. M. Nagorney, J. Rubin, D. R"— Presentation transcript:

1 Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours† 
M.A.O. Kinney, M.E. Warner, D.M. Nagorney, J. Rubin, D.R. Schroeder, P.M. Maxson, M.A. Warner  British Journal of Anaesthesia  Volume 87, Issue 3, Pages (September 2001) DOI: /bja/ Copyright © 2001 British Journal of Anaesthesia Terms and Conditions

2 Fig 1 Percentage of patients receiving octreotide intraoperatively. Octreotide was available on a compassionate-use basis from 1984 to 1987 and received FDA approval in Its intraoperative use began in 1988 for the patients in our study. British Journal of Anaesthesia  , DOI: ( /bja/ ) Copyright © 2001 British Journal of Anaesthesia Terms and Conditions


Download ppt "M. A. O. Kinney, M. E. Warner, D. M. Nagorney, J. Rubin, D. R"

Similar presentations


Ads by Google